What is the first biochemical abnormality in the workup for Cushing's syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First Biochemical Abnormality in Cushing's Workup

Loss of the normal circadian rhythm of cortisol secretion, detected by late-night salivary cortisol (LNSC), is typically the earliest biochemical abnormality in Cushing's syndrome and should be the preferred initial screening test. 1

Why LNSC Detects Abnormalities First

  • LNSC identifies loss of the normal cortisol nadir that occurs at night, which is one of the earliest physiologic derangements in Cushing's syndrome 1
  • The test has sensitivity of 95-100% and specificity of 95-100%, making it both highly sensitive and specific 1, 2
  • LNSC becomes abnormal earlier than other tests in the disease course, particularly before 24-hour urinary free cortisol (UFC) and dexamethasone suppression testing 1
  • In monitoring for recurrence after surgery, LNSC detects elevated cortisol levels earlier than 1-mg DST, while UFC is usually the last test to become abnormal 1

Comparison with Other Initial Tests

24-Hour Urinary Free Cortisol (UFC)

  • UFC has sensitivity of 89% and specificity of 100% in pediatric populations 1
  • However, UFC is usually the last test to become abnormal in patients with mild or early Cushing's syndrome 1
  • In mild Cushing's syndrome, UFC may be only slightly elevated or even normal, often less than 3-fold above the upper limit of normal 1, 3
  • The test requires at least 2-3 collections due to high intra-patient variability (up to 50%) 1, 2

Overnight 1-mg Dexamethasone Suppression Test (DST)

  • DST has high sensitivity (>90%) but lower specificity compared to LNSC 1
  • This test assesses impaired glucocorticoid feedback, which may not be the earliest abnormality 1
  • DST is particularly prone to false positives from medications, estrogen use, and increased cortisol-binding globulin 1, 4

Recommended Diagnostic Approach

Initial Screening Strategy

  • Perform 2-3 LNSC measurements on consecutive days as the first-line screening test 2
  • If clinical suspicion is high, perform multiple tests simultaneously (LNSC, UFC, and DST) rather than sequentially 2
  • Sampling saliva at usual bedtime rather than strictly at midnight can decrease false positive results 1

Important Caveats

  • Do not perform LNSC in night-shift workers or patients with disrupted circadian rhythms, as the test relies on normal sleep-wake cycles 1, 4
  • Multiple sequential LNSC measurements are particularly useful for cyclic Cushing's syndrome, where patients exhibit weeks to months of normal cortisol secretion interspersed with excess episodes 1
  • Mass spectrometry methods have better sensitivity than immunoassay but at the expense of reduced specificity 1

When LNSC is Not Ideal

  • For patients with renal impairment (CrCl <60 mL/min) or significant polyuria (>5 L/24h), LNSC is preferred over UFC 1
  • For shift workers or those with disrupted sleep schedules, DST may be more appropriate than LNSC 4
  • In women taking oral estrogen-containing contraceptives, DST may be less reliable and LNSC should be prioritized 2

Clinical Bottom Line

LNSC detects the earliest biochemical abnormality—loss of circadian rhythm—and should be the first test ordered in most patients with suspected Cushing's syndrome. 1, 2 The test becomes abnormal before UFC and often before DST shows impaired suppression, making it the most sensitive early marker of the disease. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosing Cushing's Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Cushing's Syndrome with Dexamethasone Suppression Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.